Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Analysts at Cormark lowered their FY2024 earnings per share estimates for Cresco Labs in a note issued to investors on Monday, November 11th. Cormark analyst J. Pytlak now forecasts that the company will post earnings per share of ($0.21) for the year, down from their previous forecast of ($0.17). Cormark currently has a “Hold” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.19) per share. Cormark also issued estimates for Cresco Labs’ FY2025 earnings at $0.03 EPS.
Other research analysts have also recently issued reports about the stock. Ventum Cap Mkts raised shares of Cresco Labs to a “strong-buy” rating in a report on Friday, August 9th. Needham & Company LLC reiterated a “hold” rating on shares of Cresco Labs in a research report on Monday, August 12th. Finally, Roth Capital raised Cresco Labs to a “strong-buy” rating in a report on Sunday, November 10th. Three equities research analysts have rated the stock with a hold rating, two have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $2.50.
Cresco Labs Stock Down 2.8 %
Shares of Cresco Labs stock opened at $1.40 on Thursday. Cresco Labs has a one year low of $1.02 and a one year high of $2.65. The company has a market cap of $683.40 million, a P/E ratio of -7.20 and a beta of 1.88. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.30 and a current ratio of 2.00. The firm has a fifty day moving average of $1.58 and a two-hundred day moving average of $1.70.
Cresco Labs Company Profile
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
See Also
- Five stocks we like better than Cresco Labs
- 3 Tickers Leading a Meme Stock Revival
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- The 3 Best Retail Stocks to Shop for in August
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- What Does a Stock Split Mean?
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.